Host: Govindraj Ethiraj, Founder of The Core [00:00:58].
Featured Guest: Dr. Shivkumar Kalyan Raman, CEO of the Anusandhan National Research Foundation (ANRF). Former CTO for the Energy Industry in Asia at Microsoft, former Chief Scientist for IBM Research in Australia, and former tenured professor in the United States [00:01:32, ].
Disclaimer: Orignal content owned by or sourced from third parties. It does not represent the views of 'Nuggets' platform or it's team. AI is used extensively across this platform including for summaries. Accuracy is not guaranteed, there can be mistakes. Any info or content on this platform is not a financial, legal, or investment advice. Do your own research. Refer for complete disclosures:- Terms of Use · Full Disclaimer
The Apex Mandate: The Anusandhan National Research Foundation (ANRF) is established as an apex statutory body designed to catalyze, manage, and transform India's Research and Development (R&D) ecosystem, specifically addressing historically insufficient R&D expenditures [00:01:06].
Financial Scale: The total capital pool under management adds up to almost ₹1,500,000,000,000 (₹1.5 lakh crore), split across multiple structural funding mechanisms [00:01:20].
Structural Blueprint: Dr. Kalyan Raman notes that ANRF is an "institutional innovation" mirroring the architecture of the UIDAI during the creation of Aadhaar [00:07:43]. ANRF functions as the primary statutory umbrella housing specialized funds:
ANRF Core: Dedicated to long-horizon fundamental research grants, similar to the U.S. National Science Foundation (NSF) [00:07:15].
Research, Development, and Innovation (RDI) Fund: A special purpose fund targeting commercial deep tech [00:08:02].
ANRF Innovation Fund: A newly operationalized vehicle designed to deploy intermediate asset classes and blended finance instruments [00:08:10].
2. The Operationalization of the RDI Scheme
Timeline Chronology:
November 3, 2025: The RDI scheme is officially announced by Prime Minister Narendra Modi [00:02:48].
Late January 2026: Two primary statutory second-level fund managers—the Technology Development Board (TDB) and the Biotechnology Industry Research Assistance Council (BIRAC)—are fully operationalized and issue official Calls for Proposals (CFPs) [00:02:56].
May 2026: TDB becomes the first out of the gate to finalize allocations and publicly announce its initial cohort during a dedicated event chaired by Dr. Jitendra Singh, Minister of State for Science and Technology [00:03:09].
Governance Architecture: The evaluation and selection of private sector ventures are managed entirely via professional, independent investment committees; government personnel are excluded from direct investment voting choices to ensure commercial viability [00:13:35].
Defining the Asset Class: The RDI fund is actively engineering a new domestic asset class of "patient capital" explicitly tailored for R&D-heavy deep tech [00:03:43]. This accommodates ventures that are highly time-intensive (prolonged paths to clinical trials or first revenues) even if they are not inherently capital-intensive [00:22:12].
Deployment Mechanisms: Capital is injected via non-dilutive, long-term debt, convertibles, or blended customized instruments to prevent the premature dilution of foundational equity [00:03:30].
Ticket Sizes and Co-investment Parameters:
Individual project funding ranges from ₹50 crore to ₹250 crore [00:06:08].
The RDI scheme enforces a strict 50% maximum exposure limit on any single project budget [00:06:17].
Example: A maximum disbursement of ₹250 crore from the RDI fund indicates a co-financed underlying corporate project scale of ₹500 crore [00:06:23].
Eligibility Parameters: Funding from the RDI pool is strictly limited to commercial, private-sector entities that are management-controlled by resident Indian citizens [00:05:16, 00:19:55]. Eligible technologies must sit at Technology Readiness Level 4 (TRL 4) or higher, meaning the core science has already achieved partial validation and is ready for translation or commercial scaling [00:05:19].
Key Commercial Entities & Vectors (22 Total Companies):
Ather Energy: Advanced electric mobility and generalized energy technology applications [00:02:04, 00:25:13].
IdeaForge & The E-Plane Company: High-end unmanned aerial systems (UAVs), advanced rocketry, and integrated aerospace-drone crossovers [00:02:04, 00:18:03].
GalaxEye: Space technology, low Earth orbit (LEO) satellite deployment, and integrated earth observation data services [00:04:17, 00:18:21].
Sector Whitelisting: The fund supports a broad array of critical sectors, including space tech, quantum computing, advanced semiconductors, communication networks, applied AI in healthcare, biotechnology, precision oncology, bio-fuels, and advanced manufacturing [00:04:26, 00:17:25, 00:24:45].
5. Bridging Academic Innovation and Commercial Translation
The Two-Sector Pipeline Strategy: Dr. Kalyan Raman defines a distinct bifurcation of roles designed to optimize the translation pipeline [00:10:05]:
Not-For-Profit Sector (Academia, Labs, Section 8 Entities): Absorbs upstream foundational grants to manage early-stage research and establish use-case prototypes [00:09:53].
For-Profit Private Sector: Functions as the primary engine to ingest technology transfers, deploy patient capital on corporate balance sheets, and scale ultimate economic opportunities [00:05:27, 00:10:16].
Broadening Excellence: To fix India's narrow distribution of top-tier academic R&D excellence, ANRF is actively conditioning grants on structural partnerships that pair emerging tier-2/3 research institutions with highly established academic centers [00:20:36].
"Maha" Class Mission Programs: ANRF is initiating high-impact, mission-oriented acceleration programs labeled "Maha" programs. Modeled after DARPA's focused solicitations, these are structured to drive laboratory discoveries into immediate societal leapfrog demonstrators and validated commercial products [00:09:34].
6. Global Parallels, Private Sector R&D, and the Unfinished Agenda
Private R&D Discrepancy: Addressing structural criticisms that Indian industry under-invests in deep R&D relative to peers like China, the RDI fund explicitly invites companies of all sizes—from micro-startups to ₹10,000-crore conglomerate subsidiaries (e.g., Tejas Networks under the Tata Group)—provided the proposal focuses on standalone, frontier research rather than run-of-the-mill engineering optimizations [00:18:24, 00:19:07].
Systemic Intersections (The Unfinished Agenda): Dr. Kalyan Raman notes that financial engineering is merely a single facet of deep-tech self-reliance. True structural scaling demands tackling the adjacent hurdles [00:27:49]:
Procurement Integration: Direct lines connecting early-stage domestic innovation with state and sovereign public procurement pipelines [00:28:05].
Regulatory Synchronization: Overhauling slower regulatory oversight pathways that delay clinical validation cycles in med-tech and biotech [00:28:08].
Blended Capital Aggregation: Creating highly scalable legal structures to funnel domestic Corporate Social Responsibility (CSR) and philanthropic capital pools cleanly into advanced scientific infrastructure [00:28:39].
Jun 2, 2026
Finding Balance: Growth, Income and Liquidity | 1 Jun 2026 | Morgan Stanley
Host: Representative from Morgan Stanley presenting The Alts Report 00:00:32 https://youtu.be/a2W8YMcD4F0?t=0h0m32s . Guest: Troy Geski, Chief Market Strategist for Future Standard 00:00:38 https://youtu.be/a2W8YMcD4F0?t=0h0m38s . Core Man…